Survivors and Chronic Cancer Patients: Hepatocellular ... · Frank T Kolligs, Alan Weiss, Steven Miles, Antonio Gasbarrini, Monica Lencioni, Luca Cicalese, Morris Sherman, Cesare

Alfredo Butera

Azienda Sanitaria Provinciale di Agrigento

U.O.C. Oncologia

V European Conference on Survivors and Chronic Cancer Patients

Palazzo Vermexio - Siracusa Friday - June 6th 2014

Hepatocellular carcinoma

Gemcitabine-Oxaliplatin Combo Effective in Advanced Liver Cancer

Journal of Hepatology 2012 September 17.

204 patients with advanced HCC treated between 2001 and 2010.

disease control rate was 66% tumor downstaging 8,5 %

Median progression free survival was 4.5 months

Median overall survival was 11 months

Julien Taieb et al .;

Thank you for your attention